NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT04411901,The Role of Vitamin D3 in Pediatric Bronchiectasis Severity,https://clinicaltrials.gov/study/NCT04411901,,COMPLETED,"Vitamin D3 therapy was effective in decreasing the frequency of pulmonary exacerbations and preserving lung functions , thereby improving the disease severity even more in non CF than CF bronchiectasis patients",NO,Cystic Fibrosis and Non CF Bronchiectasis,DRUG: Cholecalciferol (vitaminD3),"reach sufficient vitamin D level, vitamin D more than 30 ng/dl, 6 months|decrease disease severity, decrease excerbations and increase lung function, 6 months",,,Heba Omara,,ALL,CHILD,PHASE2|PHASE3,40,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,Original study,2018-03-01,2018-09-06,2019-03-20,2020-06-02,,2020-06-02,"Children hospital, Cairo, Abbasia, 02, Egypt",
